caVos Biotherapeutics

caVos develops mRNA therapies by identifying genetic variants conserved across long-lived species using evolutionary data and artificial intelligence. This approach generates a nature-validated atlas of therapeutic genetic variants prioritized for efficacy and safety in longevity applications. The company initially focuses on developing multi-target mRNA therapies for fibrosis and oncology based on these evolution-derived candidates.

Traction 7/10

Jerusalem, Israel · HQ

Founded 20218500+ followers

Biotechnology

Updated 2 days ago

Funding

Raised to date

$3.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Yuval Tabach

Professor and entrepreneur in genomics, medicine and data

Product

Features

caVos develops mRNA therapies by identifying genetic variants conserved across long-lived species using evolutionary data and artificial intelligence. This approach generates a nature-validated atlas of therapeutic genetic variants prioritized for efficacy and safety in longevity applications. The company initially focuses on developing multi-target mRNA therapies for fibrosis and oncology based on these evolution-derived candidates.